- HK$822.68m
- HK$5.58bn
- CNY4.48bn
- 23
- 89
- 20
- 37
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,205 | 4,426 | 3,931 | 2,937 | 4,476 |
Cost of Revenue | |||||
Gross Profit | 1,082 | 1,316 | 1,180 | 363 | 460 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,866 | 4,047 | 3,704 | 3,547 | 4,909 |
Operating Profit | 339 | 378 | 227 | -610 | -433 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 144 | 166 | 86.1 | -745 | -625 |
Provision for Income Taxes | |||||
Net Income After Taxes | 110 | 132 | 60.1 | -734 | -625 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 82.3 | 107 | 49.7 | -717 | -634 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 82.3 | 107 | 49.7 | -717 | -634 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.034 | 0.042 | 0.01 | -0.118 | -0.109 |